top cx logo
cx logo
Explorearrow down
search icon
arrow down

Paracetamol shortage: France limits sales to two boxes per patient

Brands including Doliprane and Efferalgan are affected. People are urged not to ‘stock up unless you need it immediately’ and to reduce daily doses

A photo of two boxes of Doliprane on a table, with the tablets outside

Patients will be limited to just two boxes of paracetamol in pharmacies and prescriptions may be limited too Pic: Pixavril / Shutterstock

France is limiting paracetamol sales to two boxes per patient, including for the brands Doliprane and Efferalgan, due to an ongoing stock shortage.

Patients without a GP prescription will be limited to two boxes.

The recommendation comes from the medicines safety agency l'Agence nationale de sécurité du médicament et des produits de santé (ANSM), as a result of continued shortages of the drug.

ANSM is also calling on patients, pharmacists, and doctors to reduce their reliance on the drug unless it is the only option. 

Read more: French pharmacists offer medical consultations in new trial

Paracetamol is most well-known as Doliprane and Efferalgan in France. It is one of the most-sold drugs without a prescription in the country.

Read more: What are the French equivalents of some common UK medicine brands?

In a statement, ANSM said: “With the approach of the winter season, and the restart of the Covid epidemic, the Collège de la médecine générale (CMG) and the pharmacist unions (FSPF and USPO) have formulated their recommendations to modify the use of paracetamol, and allow patients who have an immediate use for it to benefit first.”

It added: “When the situation allows it, take one dose three times per day every eight hours (instead of one dose four times a day every six hours)", adds the ANSM.  

It also asked that patients do not "stock up on paracetamol if you do not need it immediately", and advised that the pharmacist "may dispense a quantity of paracetamol lower than that indicated on your prescription; this is a dispensation that has been adapted to [our recommendations]".

The ANSM also reminded patients that non-steroidal, anti-inflammatory drugs, known as NSAIDs, should not be used as a replacement for paracetamol “in the case of pain and/or fever”...especially in children. NSAIDs are also contraindicated – not recommended – from the sixth month of pregnancy. 

Some of the most common NSAIDs are aspirin, ibuprofen, and naproxen. This is in contrast to paracetamol, which is an analgesic and antipyretic (pain reliever and fever reducer).

The agency added that a “quantitative quota” for paracetamol has been in place for the supply of city pharmacies since July 2022. Supplies have been “under strain” since then.

Related articles

French health body takes action to prevent Paracetamol shortage

France faces summer paracetamol shortages due to supply delays

Paracetamol to be made in France once again

Resident or second-home owner in France?
Benefit from our daily digest of headlines and how-to's to help you make the most of life in France
By joining the newsletter, you agree to our Terms & Conditions and Privacy Policy
See more popular articles
The Connexion Help Guides
featured helpguide
Healthcare in France*
Featured Help Guide
- Understand the French healthcare system, how you access it and how you are reimbursed - Useful if you are new to the French healthcare system or want a more in-depth understanding - Reader question and answer section Aimed at non-French nationals living here, the guide gives an overview of what you are (and are not) covered for. There is also information for second-home owners and regular visitors.
Get news, views and information from France